Beyond immunohaematology: The role of the ABO blood group in human diseases

Blood Transfusion

Volumn 11, Issue 4, 2013, Pages 491-499

  Liumbruno, Giancarlo Maria ^a   Franchini, Massimo ^b  

^a SAN GIOVANNI CALIBITA FATEBENEFRATELLI HOSPITAL   (Italy)

^b CARLO POMA HOSPITAL   (Italy)

Author keywords

ABO blood group; Cancer; Coronary heart disease; Infectious disease; Venous thromboembolism

Indexed keywords

BLOOD GROUP ABO SYSTEM; INFECTION; ISCHEMIC HEART DISEASE; PANCREAS CANCER; REVIEW; STOMACH CANCER; VENOUS THROMBOEMBOLISM;

ABO BLOOD-GROUP SYSTEM; CARDIOVASCULAR DISEASES; HUMANS; NEOPLASMS;

EID: 84891914100     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2013.0152-13     Document Type: Review

References (95)

1. Storry JR, Olsson ML. The ABO blood group system revisited: a review and update. Immunohematology 2009; 25: 48-59.
2. Eastlund T. The histo-blood group ABO system and tissue transplanta tion. Transfusion 1998; 38: 975-88.
3. Franchini M, Capra F, Targher G, et al. Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications. Thromb J 2007; 5: 14.
4. Franchini M, Favaloro EJ, Targher G, Lippi G. ABO blood group, hypercoagulability, and cardiovascular and cancer risk. Crit Rev Clin Lab Sci 2012; 49: 137-49.
5. Preston AE, Barr A. The plasma concentration of factor VIII in the normal population. Br J Haematol 1964; 10: 238-45.
6. Moeller A, Weippert-Kretschmer M, Prinz H, Kretschmer V. Influence of ABO blood groups on primary hemostasis. Transfusion 2001; 41: 56-60.
7. O'Donnell JS, Lasffan MA. The relationship between ABO histo-blood group, factor VIII and von Willebrand factor. Transfus Med 2001; 11: 343-51.
8. Gill JC, Endres-Brooks J, Bauer PJ, et al. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987; 69: 1691-5.
9. Matsui T, Titani K, Mizuochi T. Structures of the asparagine-linked oligosaccharide chains of human von Willebrand factor. Occurrence of blood group A, B, and H(O) structures. J Biol Chem 1992; 267: 8723-31.
10. Sodetz JM, Pizzo SV, McKee PA. Relationship of sialic acid to function and in vivo survival of human factor VIII/von Willebrand factor protein. J Biol Chem 1977; 252: 5538-46.
11. Jenkins PV, O'Donnell JS. ABO blood group determines plasma von Willebrand factor levels: a biologic function after all? Transfusion 2006; 46: 1836-44.
12. Folsom AR, Wu KK, Rosamond WD, et al. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 1997; 96: 1102-8.
13. Whincup PH, Danesh J, Walker M, et al. von Willebrand factor and coronary heart disease: prospective study and meta-analysis. Eur Heart J 2002; 23: 1764-70.
14. Paré G, Chasman DI, Kellogg M, et al. Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women. PLoS Genet 2008; 4: e1000118.
15. Barbalic M, Dupuis J, Dehghan A, et al. Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels. Hum Mol Genet 2010; 19: 1863-72.
16. Qi L, Cornelis MC, Kraft P, et al. Genetic variants in ABO blood group region, plasma soluble E-selectin levels and risk of type 2 diabetes. Hum Mol Genet 2010; 19: 1856-62.
17. Paterson AD, Lopes-Virella MF, Waggott D, et al Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Genomewide association iden tifies the ABO blood group as a major locus associated with serum levels of soluble E-selectin. Arterioscler Thromb Vasc Biol 2009; 29: 1958-67.
18. Wu O, Bayoumi N, Vickers MA, Clark P. ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost 2008; 6: 62-9.
19. He M, Wolpin B, Rexrode K, et al. ABO blood group and risk of coronary heart disease in two prospective cohort studies. Arterioscler Thromb Vasc Biol 2012; 32: 2314-20.
20. Franchini M, Rossi C, Mengoli C, et al. ABO blood group and risk of coronary artery disease. J Thromb Thrombolysis 2012 [Epub ahead of print].
21. Jukic I, Bingulac-Popovic J, Dogic V, et al. Evaluation of ABO blood groups as a risk factor for myocardial infarction. Blood Transfus 2012; 29: 1-2.
22. Dentali F, Sironi AP, Ageno W, et al. Non-O blood type is the commonest genetic risk factor for VTE: results from a meta-analysis of the literature. Semin Thromb Hemost 2012; 38: 535-48.
23. Franchini M, Makris M. Non-O blood group: an important genetic risk factor for venous thromboembolism. Blood Transfus 2013; 11: 164-5.
24. Wautrecht JC, Galle C, Motte S, et al. The role of ABO blood groups in the incidence of deep vein thrombosis. Thromb Haemost 1998; 79: 688-9.
25. Koster T, Blann AD, Briet E, et al. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995; 345: 152-5.
26. Ohira T, Cushman M, Tsai MY, et al. ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). J Thromb Haemost 2007; 5: 1455-61.
27. Spiezia L, Campello E, Bon M, et al. ABO blood groups and the risk of venous thrombosis in patients with inherited thrombophilia. Blood Transfus 2013; 11: 250-3.
28. Whincup PH, Cook DG, Phillips AN, Shaper AG. ABO blood group and ischaemic heart disease in British men. BMJ 1990; 300: 1679-82.
29. Wiggins KL, Smith NL, Glazer NL, et al. ABO genotype and risk of thrombotic events and hemorrhagic stroke. J Thromb Haemost 2009; 7: 263-9.
30. Carpeggiani C, Coceani M, Landi P, et al. ABO blood group alleles: a risk factor for coronary artery disease. An angiographic study. Atherosclerosis 2010; 211: 461-6.
31. Reilly MP, Li M, He J, et al. Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. Lancet 2011; 377: 383-92.
32. Morelli VM, De Visser MCH, Vos HL, et al. ABO blood group genotypes and the risk of venous thrombosis: effect of factor V Leiden. J Thromb Haemost 2005; 3: 183-5.
33. Tirado I, Mateo J, Soria JM, et al. The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism. Thromb Haemost 2005; 93: 468-74.
34. Garratty G. Blood groups and disease: a historical perspective. Transfus Med Rev 2000; 14: 291-301.
35. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
36. Aird I, Bentall HH, Fraser Roberts JA. A relationship between cancer of stomach and the ABO blood groups. Br Med J 1953; 1: 799-801.
37. Clarke CA. Blood group and disease. In: Steiberg AG, editor. Progress in Medical Genetics. Volume 1. New York, NY, USA: Grune and Stratton; 1961. p. 81-119.
38. Garratty G. Do blood groups have a biological role? In: Garratty G, editor. Immunobiology of Transfusion Medicine. New York, NY, USA: Marcel Dekker, Inc.; 1994. p. 201-55.
39. Edgren G, Hjalgrim H, Rostgaard K, et al. Risk of gastric cancer and peptic ulcers in relation to ABO blood type: a cohort study. Am J Epidemiol 2010; 172: 1280-5.
40. Wang Z, Liu L, Ji J, et al. ABO blood group system and gastric cancer: a case-control study and meta-analysis. Int J Mol Sci 2012; 13: 13308-21.
41. Rizzato C, Kato I, Plummer M, et al. Risk of advanced gastric precancerous lesions in Helicobacter pylori infected subjects is influenced by ABO blood group and cagA status. Int J Cancer 2013; 133: 315-22.
42. Iodice S, Maisonneuve P, Botteri E, et al. ABO blood group and cancer. Eur J Cancer 2010; 46: 3345-50.
43. Bosetti C, Bertuccio P, Negri E, et al. Pancreatic cancer: overview of descriptive epidemiology. Mol Carcinog 2012; 51: 3-13.
44. Aird I, Lee DR, Roberts IA. ABO blood groups and cancer of oesophagus, cancer of pancreas, and pituitary adenoma. Br Med J 1960; 1: 1163-6.
45. Macafee AL. ABO blood groups and carcinoma of pancreas. Ulster Med J 1964; 33: 129-31.
46. Annese V, Minervini M, Gabbrielli A, et al. ABO blood groups and cancer of the pancreas. Int J Pancreatol 1990; 6: 81-8.
47. Vioque J, Walker AM. Pancreatic cancer and ABO blood types: a study of cases and controls. Med Clin (Barc) 1991; 96: 761-4.
48. Wolpin BM, Chan AT, Hartge P, et al. ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst 2009; 101: 424-31.
49. Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet 2009; 41: 986-90.
50. Wolpin BM, Kraft P, Gross M, et al. Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium. Cancer Res 2010; 70: 1015-23.
51. Wolpin BM, Kraft P, Xu M, et al. Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium. Cancer Epidemiol Biomarkers Prev 2010; 19: 3140-9.
52. Rizzato C, Campa D, Pezzilli R, et al. ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium. Oncol Rep 2013; 29: 637-44.
53. Moran AP, Gupta A, Joshi L. Sweet-talk: role of host glycosylation in bacterial pathogenesis of the gastrointestinal tract. Gut 2011; 60: 1412-25.
54. Risch HA, Yu H, Lu L, Kidd MS. ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study. J Natl Cancer Inst 2010; 102: 502-5.
55. Seow LJ, Kwa SB, Teoh CK. A preliminary survey of ABO blood group frequency in nasopharyngeal carcinoma in Chinese patients. Singapore Med J 1964; 4: 93-5.
56. Turkoz FP, Celenkoglu G, Dogu GG, et al. Risk factors of nasopharyngeal carcinoma in Turkey - an epidemiological survey of the Anatolian Society of Medical Oncology. Asian Pac J Cancer Prev 2011; 12: 3017-21.
57. Sheng L, Sun X, Zhang L, Su D. ABO blood group and nasopharyngeal carcinoma risk in a population of Southeast China. Int J Cancer 2013; 133: 893-7.
58. Xie J, Qureshi AA, Li Y, Han J. ABO blood group and incidence of skin cancer. PloS One 2010; 5: e11972.
59. Gates MA, Wolpin BM, Cramer DW, et al. ABO blood group and incidence of epithelial ovarian cancer. Int J Cancer 2011; 128: 482-6.
60. Lee JS, Ro JY, Sahin AA, et al. Expression of blood-group antigen A - a favorable prognostic factor in non-small-cell lung cancer. N Engl J Med 1991; 324: 1084-90.
61. Khalili H, Wolpin BM, Huang ES, et al. ABO blood group and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2011; 20: 1017-29.
62. Gates MA, Xu M, Chen WY, et al. ABO blood group and breast cancer incidence and survival. Int J Cancer 2012; 130: 2129-37.
63. Joh HK, Cho E, Choueiri TK. ABO blood group and risk of renal cell cancer. Cancer Epidemiol 2012; 36: 528-32.
64. Manuila A. Blood groups and disease-hard facts and delusions. J Am Med Assoc 1958; 167: 2047-53.
65. Wiener AS. Modern blood group mythology. J Forensic Med 1960; 7: 166-76.
66. Wiener AS. Controversy in human genetics. Blood groups and disease. Am J Hum Genet 1970; 22: 476-83.
67. D'Adamo PJ. Cook Right 4 Your Type. New York, NY (USA): GP Pumam's Sons; 1999.
68. nd ed. Oxford, England: Oxford University Press; 1976.
69. Mourant AE, Kopéc AC, Domaniewska-Sobczak K. Blood Groups and Diseases. Oxford, England: Oxford University Press; 1978.
70. Lalueza-Fox C, Gigli E, de la Rasilla M, et al. Genetic characterization of the ABO blood group in Neandertals. BMC Evol Biol 2008; 8: 342.
71. Crainic K, Durigon M, Oriol R. ABO tissue antigens of Egyptian mummies. Forensic Sci Int 1989; 43: 113-24.
72. Fry AE, Griffiths MJ, Auburn S, et al. Common variation in the ABO glycosyltransferase is associated with susceptibility to severe Plasmodium falciparum malaria. Hum Mol Genet 2007; 17: 567-76.
73. Borén T, Falk P, Roth KA, et al. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 1993; 262: 1892-95.
74. Swerdlow DL, Mintz ED, Rodriguez M, et al. Severe life-threatening cholera associated with blood group O in Peru: implications for the Latin American epidemic. J Infect Dis 1994; 170: 468-72.
75. Yamamoto F, Cid E, Yamamoto M, Blancher A. ABO research in the modern era of genomics. Transfus Med Rev 2012; 26: 103-18.
76. Cserti CM, Dzik WH. The ABO blood group system and Plasmodium falciparum malaria. Blood 2007; 110: 2250-8.
77. Loscertales MP, Owens S, O'Donnell J, et al. ABO blood group phenotypes and Plasmodium falciparum malaria: unlocking a pivotal mechanism. Adv Parasitol 2007; 65: 1-50.
78. Rowe JA, Opi DH, Williams TN. Blood groups and malaria: fresh insights into pathogenesis and identification of targets for intervention. Curr Opin Hematol 2009; 16: 480-7.
79. Cserti-Gazdewich CM, Mayr WR, Dzik WH. Plasmodium falciparum malaria and the immunogenetics of ABO, HLA, and CD36 (platelet glycoprotein IV). Vox Sang 2011; 100: 99-111.
80. Panda AK, Panda SK, Sahu AN, et al. Association of ABO blood group with severe falciparum malaria in adults: case control study and meta-analysis. Malar J 2011; 10: 309.
81. Timmann C, Thye T, Vens M, et al. Genome-wide association study indicates two novel resistance loci for severe malaria. Nature 2012; 489: 443-6.
82. Aird I, Bentall HH, Mehigan JA, Roberts JA. The blood groups in relation to peptic ulceration and carcinoma of colon, rectum, breast, and bronchus; an association between the ABO groups and peptic ulceration. Br Med J 1954; 2: 315-21.
83. Dickey W, Collins JS, Watson RG, et al. Secretor status and Helicobacter pylori infection are independent risk factors for gastroduodenal disease. Gut 1993; 3: 351-3.
84. Ishijima N, Suzuki M, Ashida H, et al. BabA-mediated adherence is a potentiator of the Helicobacter pylori type IV secretion system activity. Biol Chem 2011; 286: 25256-64.
85. Hutson AM, Atmar RL, Graham DY, Estes MK. Norwalk virus infection and disease is associated with ABO histo-blood group type. J Infect Dis 2002; 185: 1335-7.
86. Tan M, Jiang X. Association of histo-blood group antigens with susceptibility to norovirus infection may be strain-specific rather than genogroup dependent [letter]. J Infect Dis 2008; 198: 940-1.
87. Stowell SR, Arthur CM, Dias-Baruffi M, et al. Innate immune lectins kill bacteria expressing blood group antigen. Nat Med 2010; 16: 295-301.
88. Lokireddy S, Sarojamma V, Ramakrishna V. Genetic predisposition to chikungunya: a blood group study in chikungunya affected families. Virol J 2009; 6: 77.
89. Kumar NC, Nadimpalli M, Vardhan VR, et al. Association of ABO blood groups with Chikungunya virus. Virol J; 7: 140.
90. Berger SA, Young NA, Edberg SC. Relationship between infectious diseases and human blood type. Eur J Clin Microbiol Infect Dis 1989; 8: 681-9.
91. Moulds JM, Moulds JJ. Blood group associations with parasites, bacteria, and viruses. Transfus Med Rev 2000; 14: 302-11.
92. Mollicone R, Trojan J, Oriol R. Appearance of H and B antigens in primary sensory cells of the rat olfactory apparatus and inner ear. Brain Res 1985; 349: 275-9.
93. Villarroya H, Dalix AM, Paraut M, et al. Differential susceptibility to experimental allergic encephalomyelitis (EAE) in genetically defined A+ and A- rabbits. Autoimmunity 1990; 6: 47-60.
94. St John JA, Claxton C, Robinson MW, et al. Genetic manipulation of blood group carbohydrates alters development and pathfinding of primary sensory axons of the olfactory systems. Dev Biol 2006; 298: 470-84.
95. Chehrehasa F, Key B, St John JA. The cell surface carbohydrate blood group A regulates the selective fasciculation of regenerating accessory olfactory axons. Brain Res 2008; 1203: 32-8.